Navigation Links
Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis

nam lysine for inhalation in people with CF. Each patient's participation in the study will last up to 18 months. Patients will receive treatment with 75 mg of aztreonam lysine for inhalation with the same regimen they received in AIR-CF1 or AIR-CF2 (BID or TID daily).

Gilead anticipates that data from AIR-CF1 will be available in the second quarter of 2007 and plans to submit a New Drug Application (NDA) for aztreonam lysine for inhalation for the treatment of people with CF who have pulmonary P. aeruginosa to the U.S. FDA in the second half of 2007.

About Aztreonam Lysine for Inhalation

Aztreonam lysine for inhalation is an antibiotic candidate currently being studied in Phase III clinical trials as a treatment for people with CF who have pulmonary P. aeruginosa. Aztreonam has potent activity against Gram-negative bacteria such as P. aeruginosa. Aztreonam formulated with arginine is a FDA-approved agent for intravenous administration. Aztreonam lysine for inhalation is a proprietary inhaled formulation of aztreonam and has been designated with orphan drug status in the United States and Europe.

About PARI and the eFlow Electronic Nebulizer

Aztreonam lysine is delivered through a novel inhalation device, the eFlow Electronic Nebulizer, developed by PARI Pharma GmbH. The eFlow is an electronic, portable nebulizer that enables efficient aerosolization of liquid medications via a vibrating, perforated membrane.

PARI is dedicated to advancing aerosol therapies through innovative device and formulation technologies. PARI develops and manufactures aerosol delivery systems for patients with lung diseases, and was a partner in developing the aztreonam lysine formulation.

About Cystic Fibrosis

Today, more than 30,000 people in the United States have CF. CF is a chronic, debilitating genetic disease. A major characteristic of CF is production of abnormally thick, sticky mucus in the lungs, trapping bacteria and predispo
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Second Phase III Study Evaluating Gileads Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
2. Second Phase III Study Evaluating Gileads Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
3. Phase III Study Evaluating Gileads Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
4. Gilead Announces Achievement of Primary Efficacy Endpoint in Second Phase III Study of Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis
5. Gilead Announces Presentation of Long-Term Data for Ambrisentan, a Potential Treatment for Patients With Pulmonary Arterial Hypertension
6. Data from Preclinical Studies of Gilead Nucleotide Compound GS 9219 to be Presented at AACR
7. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
8. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
10. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
11. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
Post Your Comments:
(Date:10/31/2014)... 31, 2014 ThynkWare ( www.thynkware.com ) is ... text and email messages using their thoughts. ... by ThynkWare,s founder, Duane Cash , which is ... This technology allows users to control their devices in ... thought. ThynkWare provides the interface layer between ...
(Date:10/31/2014)... Oct. 30, 2014 Migranade, Inc. announced today ... available to the 36 million U.S. migraine sufferers November, ... that targets the actual cause of migraines and not ... and not the source Migranade is assured to be ... Migraine Relief is available at http://www.migranade.com and ...
(Date:10/31/2014)... 31, 2014  AbbVie (NYSE: ABBV ... quarter ended Sept. 30, 2014. ... our business with double-digit growth from HUMIRA and ... nearly 14 percent in the quarter excluding lipids," ... officer, AbbVie.  "We exceeded our outlook for the ...
Breaking Medicine Technology:ThynkWare Speech Helps Those with ALS and Locked-In Syndrome Translate Thought to Speech on Their Smartphone Devices 2Game Changing Migraine Medication To Be Available November 2014 2AbbVie Reports Third-Quarter 2014 Financial Results 2AbbVie Reports Third-Quarter 2014 Financial Results 3AbbVie Reports Third-Quarter 2014 Financial Results 4AbbVie Reports Third-Quarter 2014 Financial Results 5AbbVie Reports Third-Quarter 2014 Financial Results 6AbbVie Reports Third-Quarter 2014 Financial Results 7AbbVie Reports Third-Quarter 2014 Financial Results 8AbbVie Reports Third-Quarter 2014 Financial Results 9AbbVie Reports Third-Quarter 2014 Financial Results 10AbbVie Reports Third-Quarter 2014 Financial Results 11AbbVie Reports Third-Quarter 2014 Financial Results 12AbbVie Reports Third-Quarter 2014 Financial Results 13AbbVie Reports Third-Quarter 2014 Financial Results 14AbbVie Reports Third-Quarter 2014 Financial Results 15AbbVie Reports Third-Quarter 2014 Financial Results 16AbbVie Reports Third-Quarter 2014 Financial Results 17AbbVie Reports Third-Quarter 2014 Financial Results 18AbbVie Reports Third-Quarter 2014 Financial Results 19AbbVie Reports Third-Quarter 2014 Financial Results 20AbbVie Reports Third-Quarter 2014 Financial Results 21AbbVie Reports Third-Quarter 2014 Financial Results 22AbbVie Reports Third-Quarter 2014 Financial Results 23AbbVie Reports Third-Quarter 2014 Financial Results 24
... WASHINGTON, Sept. 16 Policymakers and market leaders looking for ... are looking to the medical home to advance quickly and ... will converge on Washington, DC, Oct. 21, 2010 to examine ... means to deliver health care with better quality outcomes and ...
... Files New Patent Applications -- SHANGHAI, Sept. 16 /PRNewswire-Asia-FirstCall/ -- ... ... ... first_result; // Results are keyed by longUrl, so we need to grab the first one. for (var ...
Cached Medicine Technology:Patient-Centered Primary Care Collaborative Convenes Annual Summit 2Patient-Centered Primary Care Collaborative Convenes Annual Summit 3China-Biotics Files New Patent Applications 2China-Biotics Files New Patent Applications 3China-Biotics Files New Patent Applications 4China-Biotics Files New Patent Applications 5China-Biotics Files New Patent Applications 6China-Biotics Files New Patent Applications 7
(Date:10/31/2014)... (PRWEB) October 31, 2014 This ... has amazing health effects for practitioners. , ... a Doctor of Science and Movement specializing in ... dedication to pelvic floor reeducation that traditional abdominal ... incontinence, Diastasis Recti, Prolepses, etc. , The Hipopressives ...
(Date:10/31/2014)... News) -- Surgery for low back pain caused by ... States you live, a new report says. "Nearly ... at some point in their lives, and about 30 ... a spine problem," co-author Brook Martin, of the Dartmouth ... a college news release. In spinal stenosis, thickening ...
(Date:10/31/2014)... older Americans say that either they or a family ... to the latest issue of The Gerontological Society of ... PP&AR ), which goes on to show that Americans ... honor patients, end-of-life health care wishes. , This ... Options ," features 12 articles that present new ways ...
(Date:10/31/2014)... October 31, 2014 Urban Hydroponics, Inc. ... today announced it has signed a Binding Letter of ... the urban cultivation sector - Urban Cultivator Inc. (“Urban ... and W3 Metal Inc. (“W3 Metal” and together with ... Pursuant to the LOI and an earlier non-binding ...
(Date:10/31/2014)... Triple Board Certified surgeon Dr. Jeffrey ... transform the appearance of military veteran Joseph Jones. ... Plastic and Reconstruction Surgery (AAFPRS) Faces of Honor program, ... hair Jones lost during an IED blast almost ten ... procedure, valued around $16,000, took Dr. Epstein over eight ...
Breaking Medicine News(10 mins):Health News:Super Models and European Celebrities’ Secret Flat Tummy System Comes to America 2Health News:Super Models and European Celebrities’ Secret Flat Tummy System Comes to America 3Health News:Spinal Surgery Varies by Region in U.S.: Study 2Health News:Advance directives can benefit patients, families, and health care system 2Health News:Urban Hydroponics Inc. Signs Definitive Agreement to Merge with Canadian Hydroponics Companies 2Health News:Urban Hydroponics Inc. Signs Definitive Agreement to Merge with Canadian Hydroponics Companies 3Health News:Urban Hydroponics Inc. Signs Definitive Agreement to Merge with Canadian Hydroponics Companies 4Health News:Urban Hydroponics Inc. Signs Definitive Agreement to Merge with Canadian Hydroponics Companies 5Health News:Miami Hair Restoration Specialist Transforms Wounded Soldier 2
... doctors,and six others have been charged in four ... schemes totaling $56 million, the Department of,Justice Criminal ... of Florida announced today., One indictment alleges ... Harris, 57, and Enrique Gonzalez, 62, conspired to ...
... hospitals, physicians,pharmaceutical companies, and insurance providers that make ... spending $55 billion on,telecommunications services over the next ... by the Insight Research Corporation. According to,the market ... on,telecommunications services will grow at a compounded rate ...
... 29 GNC wants to help honorably,discharged veterans ... program., The program is designed to help ... next journey in life. Through Dec. 31, 2008, ... normal franchise fee.,Service-disabled veterans receive additional benefits, including ...
... May 29 Alexza,Pharmaceuticals, Inc. (Nasdaq: ... has joined the company as Vice President, ... in the development and,execution of clinical and ... product candidates. Dr. Clarke was most recently,Vice ...
... May 29, 2008 Aging dental bridges are a maintenance headache ... to floss, often decay, and require replacement with longer bridges. ... to nowhere should be replaced with permanent dental implants. ... bridges in our mouths for twenty years or more. They ...
... 2007 ... date in 2008, VANCOUVER, May 29 /PRNewswire-FirstCall/ - CRH Medical ... three months ended March 31, 2008 compared to $0.50 million for ... Company,s net,loss decreased to $0.96 million ($0.02 per share) for the ...
Cached Medicine News:Health News:Three Miami Area Doctors and Six Others Charged in $56 Million Health Care Fraud Schemes 2Health News:Three Miami Area Doctors and Six Others Charged in $56 Million Health Care Fraud Schemes 3Health News:Three Miami Area Doctors and Six Others Charged in $56 Million Health Care Fraud Schemes 4Health News:Three Miami Area Doctors and Six Others Charged in $56 Million Health Care Fraud Schemes 5Health News:Healthcare Industry Spending on Telecommunications Services Hits $55 Billion Over Next Five Years, Says Insight Research 2Health News:Veterans to Receive Business Discounts Through GNC's New Veterans Franchising Opportunity 2Health News:Anthony Clarke, PhD Joins Alexza Pharmaceuticals as Vice President, International Development Operations 2Health News:Anthony Clarke, PhD Joins Alexza Pharmaceuticals as Vice President, International Development Operations 3Health News:Dental implants preferred option for aging bridges 2Health News:CRH Medical reports Q1 2008 results 2Health News:CRH Medical reports Q1 2008 results 3Health News:CRH Medical reports Q1 2008 results 4
... WaveScan WaveFront System is an ophthalmic diagnostic ... wavefront aberrations of the human eye using ... be used to determine regular (sphero-cylindrical) refractive ... or blurry vision in the human eye. ...
... Trusted technology. Precisely measured. ... precision diagnostics, measuring refractive error ... of the eye. ,As part ... Zyoptix™ Diagnostic Workstation, Zywave II ...
ZYMAR™ ophthalmic solution is an anti-infective prescription eye drop that your doctor may instruct you to use if you have an eye infection caused by bacteria. Bacterial conjunctivitis is the e...
... P.M.® lets you sleep on ... in the morning awake with ... ready to take on the ... comfort and protection, this preservative-free ...
Medicine Products: